Skip to content

Debt-to-assets at other companies

Pfizer logo
PfizerPFE
0.3×0.0×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
0.7×+0.2×
AbbVie logo
AbbVieABBV
0.5×0.0×
Immunome logo
ImmunomeIMNM
0.0×
Arcus Biosciences logo
Arcus BiosciencesRCUS
0.1×+0.1×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
0.0×

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.

Based on the most recent quarter.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s debt-to-assets?
SELLAS Life Sciences Group, Inc. (SLS) reported debt-to-assets of 0× in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s debt-to-assets changed year-over-year?
SELLAS Life Sciences Group, Inc.'s debt-to-assets decreased by 69.5% year-over-year, from 0× to 0×.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s debt-to-assets?
Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s debt-to-assets has grown at a -9.9% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.